“We believe the strong patient protections in Part D will help everyone get access to the drugs that are right for them at a lower cost,” Mr Azar said during a recent speech, “but we want your input on how that should work.”
Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections, however, the costs of these treatments are becoming more of a burden for patients.
According to a recent study, nonadherence among Medicaid insured patients with HIV led to an increase in health care resource utilization and overall costs.
Recent research examined a new simulation modeling framework to predict how effective certain pre- and post-exposure prophylaxis drugs will work to prevent HIV infection.
Long-term antiretroviral therapy among a cohort of veterans may be associated with cancer prevention, particularly in incidences of AIDS-defining cancers, according to recent research.